A practical reference on GHRH receptor: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-01-23. Anything still debated is marked as such rather than presented as settled.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH analog, not a steroid |
| Backbone length | 29 amino acids | Based on GRF(1-29) |
| Substitutions | Four positions | D-Ala2, Gln8, Ala15, Leu27 |
| Appearance | White to off-white powder | Typical lyophilized research material |
| Common synonyms | Modified GRF(1-29) | Usage varies between sources |
Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
==== Metabolism ==== Atomoxetine is primarily metabolized via oxidative metabolism. The three major metabolic pathways include aromatic ring hydroxylation mainly by CYP2D6 but also other cytochrome P450 enzymes into 4-hydroxyatomoxetine, benzylic hydroxylation by an unspecified enzyme into 2-hydroxymethylatomoxetine, and N-demethylation by CYP2C19 into N-desmethylatomoxetine. In addition, N-desmethylatomoxetine undergoes hydroxylation by CYP2D6 into N-desmethyl-4-hydroxyatomoxetine. The hydroxylated metabolites of atomoxetine undergo glucuronidation via UDP-glucuronyltransferase (UGT) enzymes to form glucuronide conjugates. As previously described, first-pass metabolism of atomoxetine is substantially greater, bioavailability is lower, peak levels and total exposure are much greater, and elimination half-life is much longer in CYP2D6 poor metabolizers than in extensive metabolizers. The overall metabolism of atomoxetine is similar regardless of CYP2D6 status. In addition, 4-hydroxyatomoxetine remains the major metabolite of atomoxetine independently of CYP2D6 status. But the quantitative amounts of formed atomoxetine metabolites and their rates of formation are substantially different depending on CYP2D6 status. Studies with radiolabeled atomoxetine have shown that peak levels of radioactivity are essentially the same between CYP2D6 extensive metabolizers and CYP2D6 poor metabolizers. However, total exposure of radioactivity was larger and elimination half-life of radioactivity was longer (62 hours vs.
== January 14, 1982 (Thursday) == An Ethiopian Air Force Antonov An-26 crashed near Addis Ababa, Ethiopia while transporting a group of Ethiopian, Libyan and Cuban soldiers to a fight in Eritrea. All 73 occupants on board were killed. It the state of Hidalgo in Mexico, near the town of Atotonilco de Tula, the bodies of 13 men were found by a drainage canal. The dead men would be found to have been from Colombia, who had been arrested, as well as a Mexican taxicab driver who had helped transport them to the scene of the deaths. Mexico City Police Chief Arturo Durazo Moreno, accused by a subordinate of having planned the killings, would end up fleeing Mexico after the inauguration of a new president. Robert Dale Henderson began a spree of mostly random murders that would kill 12 people across five U.S. states, in a little more than three weeks until his arrest on February 6, starting with a beautician in Cincinnati. One week later, on January 21, he murdered a family of three in Cherry Fork, Ohio, followed by the January 24 killing of a receptionist in Charleston, South Carolina, the January 25 homicides of a doctor and a clerk in Palatka, Florida and a mother and daughter later in the day in Valdosta, Georgia. He killed a nightclub owner in Port Allen, Louisiana on January 29, and three hitchhikers in Hernando County, Florida on February 4, before approaching a deputy sheriff at a shopping center in Punta Gorda, Florida, making a confession, and surrendering.
Ari Parata is a fictional character from the Australian television soap opera Home and Away, played by Rob Kipa-Williams. The actor had given up acting and was training for a new career as an insurance adviser when he was given the character brief for Ari. He was initially unsure about returning to acting, but he felt like the character was a good fit for him and he auditioned for the role. After winning the part, Kipa-Williams realised that he would have to relocate to Sydney for filming. He had doubts about the move, but later admitted that he was happy he went through with it, as Home and Away helped him regain his love of acting. Kipa-Williams signed a three-year contract and he began filming around May 2019. He made his first appearance during the serial's season finale on 27 November 2019. Ari was introduced along with his brother Tane Parata (Ethan Browne), their nephew Nikau Parata (Kawakawa Fox-Reo), and sister-in-law Gemma Parata (Bree Peters). They were the serial's first Māori and indigenous family to join the main cast of Home and Away. The actors wanted to include as much of the Māori culture in the show as possible and worked with the producers and scriptwriters to achieve a high level of authenticity. Ari is portrayed as being very protective of his family, but he dislikes confrontation and struggles to express his emotions. Kipa-Williams believed he was "a little bit lost", which he could relate to. It quickly emerges that Ari has spent time in prison and he is frequently frustrated about the limited opportunities available to him because of his record.
Sources: en.wikipedia.org
GPCRs become desensitized when exposed to their ligand for a long period of time. There are two recognized forms of desensitization: 1) homologous desensitization, in which the activated GPCR is downregulated; and 2) heterologous desensitization, wherein the activated GPCR causes downregulation of a different GPCR. The key reaction of this downregulation is the phosphorylation of the intracellular (or cytoplasmic) receptor domain by protein kinases. Cyclic AMP-dependent protein kinases (protein kinase A) are activated by the signal chain coming from the G protein (that was activated by the receptor) via adenylate cyclase and cyclic AMP (cAMP). In a feedback mechanism, these activated kinases phosphorylate the receptor. The longer the receptor remains active the more kinases are activated and the more receptors are phosphorylated. In β2-adrenoceptors, this phosphorylation results in the switching of the coupling from the Gs class of G-protein to the Gi class. cAMP-dependent PKA mediated phosphorylation can cause heterologous desensitisation in receptors other than those activated.
=== Animal === Laboratory tests assessing the toxicity of chlordiazepoxide, nitrazepam and diazepam on mice spermatozoa found that chlordiazepoxide produced toxicities in sperm including abnormalities involving both the shape and size of the sperm head. Nitrazepam, however, caused more profound abnormalities than chlordiazepoxide.
The lambda particle is a type of subatomic particle in subatomic particle physics. Lambda is the set of logical axioms in the axiomatic method of logical deduction in first-order logic. Uppercase Lambda is often used as a stylized form of uppercase A, especially in science fiction. There is a poetical allusion to the use of Lambda as a shield blazon by the Spartans. Lambda is the von Mangoldt function in mathematical number theory. Lambda denotes the de Bruijn–Newman constant which is closely connected with Riemann's hypothesis. In statistics, lambda is used for the likelihood ratio. In statistics, Wilks's lambda is used in multivariate analysis of variance (MANOVA analysis) to compare group means on a combination of dependent variables. In the spectral decomposition of matrices, lambda indicates the diagonal matrix of the eigenvalues of the matrix. In computer science, lambda is the time window over which a process is observed for determining the working memory set for a digital computer's virtual memory management. In astrophysics, lambda represents the likelihood that a small body will encounter a planet or a dwarf planet leading to a deflection of a significant magnitude. An object with a large value of lambda is expected to have cleared its neighbourhood, satisfying the current definition of a planet. In crystal optics, lambda is used to represent a lattice period. In electrochemistry, lambda denotes the "equivalent conductance" of an electrolyte solution.
More generally, an NAD(P)H-hydrate epimerase (EC 5.1.99.6, NAD(P)HX epimerase) is a type of enzyme with systematic name (6R)-6beta-hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide 6-epimerase. Enzymes of this class, especially NAXE and its orthologs, catalyse the following chemical reaction
Sources: en.wikipedia.org
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.
The original material included a linker that binds serum albumin. A later variant removed that linker to reduce the duration of action. Catalogs and papers did not consistently adopt separate names, so both remain widely labeled with the same term.
The amino acid sequence and the presence or absence of the linker group. Mass measured by spectrometry gives an independent check that separates the two forms.
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.